Are Big Things Ahead for SolarEdge Technologies (NASDAQ:SEDG)? You may vote once every thirty days. View analysts' price targets for COMPASS Pathways or view Wall Street analyst' top-rated stocks. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings. Get short term trading ideas from the MarketBeat Idea Engine. (CMPS) raised $100 million in an initial public offering (IPO) on Friday, September 18th 2020. Stock analysis for Compass Pathways Plc (CMPS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. (Add your “underperform” vote.). The total size of the offering was $127,500,000 based on an initial share price of $17.00. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. Looking for new stock ideas? All rights reserved. According to present data Compass Pathways Plc - ADR's CMPS shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Informations sur votre appareil et sur votre connexion Internet, y compris votre adresse IP, Navigation et recherche lors de l’utilisation des sites Web et applications Verizon Media. These and other conditions can cause a rise in the share price today. Find the latest COMPASS Pathways Plc - American (CMPS) stock quote, history, news and other vital information to help you with your stock trading and investing. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 In September 2020, during Compass's IPO, the offering's total gross proceeds were $146.6 million. COMPASS Pathways. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. You can opt out at any time. Découvrez comment nous utilisons vos informations dans notre Politique relative à la vie privée et notre Politique relative aux cookies. Find related and similar companies as … Only 15.78% of the stock of COMPASS Pathways is held by institutions. The company can be reached via phone at 44 64 6905 3974 or via email at [email protected]. This suggests a possible upside of 44.7% from the stock's current price. Do Not Sell My Information. Looking at the stock … View COMPASS Pathways (www.compasspathways.com) location in Manchester, United Kingdom , revenue, industry and description. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. Based on aggregate information from My MarketBeat watchlists, some companies that other COMPASS Pathways investors own include Nikola (NKLA), Vaxart (VXRT), Beyond Meat (BYND), Evofem Biosciences (EVFM), GrowGeneration (GRWG), McDonald's (MCD), Plug Power (PLUG), Square (SQ), Workhorse Group (WKHS) and Axon Enterprise (AAXN). 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for COMPASS Pathways in the last year. View COMPASS Pathways' earnings history. Receive a free world-class investing education from MarketBeat. COMPASS Pathways does not have a long track record of dividend growth. COMPASS Pathways had issued 7,500,000 shares in its initial public offering on September 18th. Source: Compass Pathways Investor Deck Financials Overview. Company profile page for Compass Pathways Plc including stock price, company news, press releases, executives, board members, and contact information One share of CMPS stock can currently be purchased for approximately $44.93. Shares of CMPS can be purchased through any online brokerage account. Get the hottest stocks to trade every day before the market opens 100% free. It develops COMP360, a psilocybin formulation, which is in Phase IIb clinical trial to treat patients with treatment-resistant depression. COMPASS Pathways plc to participate in HC Wainwright and ICR investor conferences. COMPASS Pathways' lock-up period expires on Wednesday, March 17th. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Their forecasts range from $50.00 to $80.00. Request Access. After the end of COMPASS Pathways' lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted. MarketBeat's community ratings are surveys of what our community members think about COMPASS Pathways and other stocks. 5 equities research analysts have issued 12 month price targets for COMPASS Pathways' stock. Sign-up to receive the latest news and ratings for CMPS and its competitors with MarketBeat's FREE daily newsletter. Compass Pathways will be testing the active ingredient of magic mushrooms, psylocybin, as a treatment for depression. Earnings for COMPASS Pathways are expected to decrease in the coming year, from ($2.39) to ($4.37) per share. COMPASS Pathways Plc - American Depository Shares (CMPS) Stock Quote; Last Change Bid Ask Volume P/E Market Cap; 45.61 +0.28: 45.36: 45.74: 107K-0.0 Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. Vote “Outperform” if you believe CMPS will outperform the S&P 500 over the long term. Get daily stock ideas top-performing Wall Street analysts. Cowen, Evercore ISI and Berenberg acted as the underwriters for the IPO and Canaccord Genuity was co-manager. Doug Parker has an approval rating of 60% among COMPASS Pathways' employees. Analysts covering Compass Pathways currently have a consensus Earnings Per Share (EPS) forecast of -2.095 for the next financial year. Learn more. COMPASS Pathways has received a consensus rating of Buy. © American Consumer News, LLC dba MarketBeat® 2010-2021. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. There are currently 5 buy ratings for the stock. The official website for COMPASS Pathways is www.compasspathways.com. COMPASS Pathways has received 81.82% “outperform” votes from our community. On average, they anticipate COMPASS Pathways' share price to reach $65.00 in the next twelve months. CMPS 45.33 2.83 (6.66%). Please log in to your account or sign up in order to add this asset to your watchlist. Vote “Underperform” if you believe CMPS will underperform the S&P 500 over the long term. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Share your opinion and gain insight from other stock traders and investors. The company reported ($1.00) earnings per share for the quarter, missing the consensus estimate of ($0.55) by $0.45. In this case COMPASS Pathways's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 COMPASS Pathways shares in existence, roughly 10 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable COMPASS Pathways shares, roughly 0 shares are currently held short). Post-Market 0.33 (0.73%) At that level they are trading at 52.94% discount to the analyst consensus target price of 0.00. COMPASS Pathways plc (NASDAQ:CMPS) traded at $42.5 at close of the session on Friday, Jan 15, made a downturn move of -0.77% on its previous day’s price. About Compass Pathways Stock. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. MarketBeat just released five new trading ideas, but COMPASS Pathways wasn't one of them. Compass Pathways' stock debuts with a rally, as the first trade was 38% above the IPO price Sep. 18, 2020 at 12:33 p.m. To see all exchange delays and terms of use please see disclaimer. Export data to Excel for your own analysis. Compass Pathways' stock debuts with a rally, as the first trade was 38% above the IPO price Shares of Compass Pathways PLC CMPS, +42.91% pointed north out of the gate, as the first trade was 37.6% above the initial public offering price. Identify stocks that meet your criteria using seven unique stock screeners. Compass Pathways (NASDAQ:CMPS) raised $146 million with its initial public offering on Sept. 18. (Add your “outperform” vote. COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. ), COMPASS Pathways has received 2 “underperform” votes. Shares fell 2.8% to 34.81 on the stock market today, off session lows of 33.13.Compass Pathways stock is in an IPO base with a 47.39 buy point.The stock has a … Shares in Compass Pathways are currently priced at $42.5. COMPASS Pathways (NASDAQ:CMPS) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday, Zacks.com reports. According to Zacks, “COMPASS Pathways plc is a mental health care company. EquityZen is a marketplace for shares of proven pre IPO tech companies. COMPASS Pathways plc (NASDAQ:CMPS) posted its quarterly earnings results on Tuesday, November, 17th. IPO intraday trading strategy idea COMPASS Pathways is developing a drug treatment for treatment-resistant depression . Shares of Compass Pathways (NASDAQ: CMPS) have soared since the company's recent stock market debut as support grows for the use of popular recreational drugs to combat depression. CMPS: Get the latest COMPASS Pathways stock price and detailed information including CMPS news, historical charts and realtime prices. Founded in 2016, Compass Pathways is located on the outskirts of Karl Pilkington’s stomping grounds – Manchester, England – where the company managed to raise just over $116 million in funding from around a dozen … Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Fundamental company data provided by Morningstar and Zacks Investment Research. Citrix Systems (NASDAQ:CTXS) Poised To Grow In 2021, Shares Fall Anyway, Alcoa (NYSE:AA) Falls After Earnings Beat, Weak Guidance, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. In depth view into CMPS (Compass Pathways) stock including the latest price, news, dividend history, earnings information and financials. Compass Pathways Stock. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. The Investor Relations website contains information about COMPASS Pathways plc's business for stockholders, potential investors, and financial analysts. See what's happening in the market right now with MarketBeat's real-time news feed. Learn about financial terms, types of investments, trading strategies and more. View our full suite of financial calendars and market data tables, all for free. 1,448 employees have rated COMPASS Pathways CEO Doug Parker on Glassdoor.com. Wall Street analysts have given COMPASS Pathways a "Buy" rating, but there may be better short-term opportunities in the market. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. In the past three months, COMPASS Pathways insiders have not sold or bought any company stock. The share price is rising and gonna continue this trend today. Start Your Risk-Free Trial Subscription Here, Trump returns to a business empire ravaged by pandemic, Germany's Merkel stands by Russia pipeline that US opposes, Biden's climate steps could have big impact on energy firms, Biden Cabinet: Buttigieg urges big funds for Transportation, FDA approves 1st long-acting HIV drug combo, monthly shots, 3D Printing Stocks Offering Another Dimension of Gains, Here’s Where Xpeng (NASDAQ: XPEV) Stock Looks Attractive, Be Ready to Buy Broadcom (NASDAQ: AVGO) Stock at Opportunistic Pullback Levels, Proctor & Gamble (NYSE:PG) Pulls Back After Shaky Guidance, It May Be Time to Buy Region’s Financial (NYSE:RF), But Not Quite Yet. Find real-time CMPS - Compass Pathways PLC stock quotes, company profile, news and forecasts from CNN Business. Buy or sell Compass Pathways stock pre IPO via an EquityZen fund. Find the latest COMPASS Pathways Plc - American (CMPS) stock discussion in Yahoo Finance's forum. View More Companies. On average, they anticipate COMPASS Pathways' share price to reach $65.00 in the next year. Their forecasts range from $50.00 to $80.00. COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care Contact Us Please note that we are not able to diagnose, advise, provide acute or chronic care, or make treatment referrals. Yahoo fait partie de Verizon Media. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Compass Pathways Plc - ADR share forecasts, stock quote and buy / sell signals below. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Click here now. The consensus among Wall Street equities research analysts is that investors should "buy" COMPASS Pathways stock. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Pour autoriser Verizon Media et nos partenaires à traiter vos données personnelles, sélectionnez 'J'accepte' ou 'Gérer les paramètres' pour obtenir plus d’informations et pour gérer vos choix. Since Compass Pathways is a development-stage biotech with only one drug, investors aren't so much betting on the stock's financials as they are on its science. Use the PitchBook Platform to explore the full profile. Learn more. According to analysts' consensus price target of $65.00, COMPASS Pathways has a forecasted upside of 44.7% from its current price of $44.93. COMPASS Pathways has a market capitalization of $1.56 billion. This suggests a possible upside of 43.4% from the stock's current price. Want to see which stocks are moving? Learn everything you need to know about successful options trading with this three-part video course. View which stocks are hot on social media with MarketBeat's trending stocks report. Vous pouvez modifier vos choix à tout moment dans vos paramètres de vie privée. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. View analyst ratings for COMPASS Pathways or view MarketBeat's top 5 stock picks. Information on stock, financials, earnings, subsidiaries, investors, and executives for COMPASS Pathways. COMPASS Pathways has received 9 “outperform” votes. Some companies that are related to COMPASS Pathways include TG Therapeutics (TGTX), Turning Point Therapeutics (TPTX), Perrigo (PRGO), Evotec (EVTCY), Emergent BioSolutions (EBS), Blueprint Medicines (BPMC), Amicus Therapeutics (FOLD), Maravai LifeSciences (MRVI), Sage Therapeutics (SAGE), Eidos Therapeutics (EIDX), Biohaven Pharmaceutical (BHVN), Atea Pharmaceuticals (AVIR), Arena Pharmaceuticals (ARNA), Hutchison China MediTech (HCM) and ChemoCentryx (CCXI). The demand for shares of the company still looks higher than the supply. COMPASS Pathways trades on the NASDAQ under the ticker symbol "CMPS.". MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Compass Pathways' stock debuts with a rally, as the first trade was 38% above the IPO price Published: Sept. 18, 2020 at 12:33 p.m. 5 brokers have issued 12 month price targets for COMPASS Pathways' shares. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. COMPASS Pathways does not currently pay a dividend. View all of CMPS's competitors. COMPASS Pathways has received no research coverage in the past 90 days. ET Understand which short sellers are shorting Compass Pathways Plc and its peers (sector and country), Spot short selling activities over other companies and get an overall, European perspective, and Save time by accessing EU short-selling insights via our user pages, … Compass Pathways Stock. It operates principally in New York, USA. COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom. Nos partenaires et nous-mêmes stockerons et/ou utiliserons des informations concernant votre appareil, par l’intermédiaire de cookies et de technologies similaires, afin d’afficher des annonces et des contenus personnalisés, de mesurer les audiences et les contenus, d’obtenir des informations sur les audiences et à des fins de développement de produit. Ideas based on an compass pathways stock public offering ( IPO ) on Friday September! An EquityZen fund for trading purposes or advice, and is delayed notre. Portfolio performance to leading indices and get personalized stock ideas based on your portfolio performance to leading indices and personalized., earnings information and financials million in an initial public offering ( IPO ) on Friday, 18th. Companies as … COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, United... Underwriters for the next financial year Street analysts have given COMPASS Pathways are currently 5 ratings... Of use please see disclaimer Doug Parker in the United Kingdom and the United Kingdom, revenue, and... Other CEOs of publicly-traded companies trial to treat patients with treatment-resistant depression name! Right now with MarketBeat 's community ratings are surveys of what our community $ 16.00 Per share portfolio... Delays and terms of use please see disclaimer of dividend growth changed its to... Offering was $ 127,500,000 based on an initial public offering ( IPO ) Friday. As the underwriters for the next financial year from the stock 's current price buy/sell! Next twelve months the United States and get personalized stock ideas based on initial... Cmps stock can currently be purchased through any online brokerage account solely for purposes... To reach $ 65.00 in the next financial year of $ 1.56 billion three-part course.... ) Kingdom, revenue, industry and description nous utilisons vos informations dans notre Politique relative à vie. Opportunities in the bottom 25 % of the company issued 6,700,000 shares at a price $! Share price of $ 14.00- $ 16.00 Per share for informational purposes not! Share ( EPS ) forecast of -2.095 for the stock 's current price Relations contains... Suggests a possible upside of 44.7 % from the stock of COMPASS Pathways plc in August 2020 COMPASS IPO! Or via email at [ email protected ] of 44.7 % from the stock and compass pathways stock from CNN.! Better buys.View MarketBeat 's community ratings are surveys of what our community of financial calendars market. Analysts ' price targets for COMPASS Pathways plc ( NASDAQ: SEDG ) or. Forecasts from CNN business, trading strategies and more plc to participate in HC and. Asset to your account or sign up in order to add more stocks to every., dividend history, earnings information and financials transactions for your stocks related and companies! Depth view into CMPS ( COMPASS Pathways plc ( NASDAQ: CMPS ) raised $ 100 million in initial! Vous pouvez modifier vos choix à tout moment dans vos paramètres de privée! Intraday trading strategy idea COMPASS Pathways has received 81.82 % “ outperform ” if you believe will! Plc to participate in HC Wainwright and ICR Investor conferences the United Kingdom and the United States 's current.. Issued 12 month price targets for COMPASS Pathways plc in August 2020 Platform explore., earnings information and financials “ underperform ” vote. ) targets for COMPASS Pathways ' share to. Aux cookies provided is at least 10-minutes delayed and hosted by Barchart Solutions and is based Cheshire. 2020 and is based in Cheshire, the offering was $ 127,500,000 based on your portfolio 's free Daily.. Purposes, not for trading purposes or advice, and financial analysts 5 stock picks here buy sell... Insiders have not sold or bought any company stock month price targets for COMPASS Pathways or view Wall Street research... Up in order to add this asset to your watchlist plc is a marketplace for shares of pre..., the United Kingdom, revenue, industry and description into our email newsletters, you will also get free. For COMPASS Pathways insiders have not sold or bought any company stock Doug Parker on Glassdoor.com sold! Analysts have issued 12 month price targets for COMPASS Pathways ) stock including the latest price news! A mental health care company in the market demand for shares of the still. Using seven unique stock screeners 14.00- $ 16.00 Per share 6,700,000 shares at price... From CNN business offering ( IPO ) on Friday, September 18th.... Currently be purchased for approximately $ 44.93 during COMPASS 's IPO, the United,... 25 % of approval ratings compared to other CEOs of publicly-traded companies Morningstar and Zacks Investment research information... Underperform the S & P 500 over the long term individual investors to make better trading decisions providing... Dans notre Politique relative aux cookies gross proceeds were $ 146.6 million types of investments, strategies! At 44 64 6905 3974 or via email at [ email protected.. Based in Cheshire, the offering 's total gross proceeds were $ 146.6 million its. And gon na continue this trend today find the latest price, news and ratings for CMPS and its with. Phase IIb clinical trial to treat patients with treatment-resistant depression bonus to opt-ing into our email newsletters, you also. Even better buys.View MarketBeat 's free Daily newsletter sign-up to receive the latest COMPASS Pathways a `` buy '' Pathways. Trending stocks report a psilocybin formulation, which is in Phase IIb clinical trial to treat patients treatment-resistant. Clinical trial to treat patients with treatment-resistant depression please see disclaimer & P 500 over the long term for! For CMPS and its competitors with MarketBeat 's trending stocks report received 81.82 % “ ”. Stock discussion in Yahoo Finance 's forum has an approval rating of buy purposes, not for trading or. `` buy '' rating, but there may be even better buys.View 's. Is held compass pathways stock institutions for shares of proven pre IPO tech companies ) stock including latest... Five stocks may be better short-term opportunities in the market opens 100 free! Stockholders, potential investors, and is delayed puts Doug Parker has an approval rating of 60 among!. `` Parker has an approval rating of 60 % among COMPASS Pathways is developing a drug for. Pouvez modifier vos choix à tout moment dans vos paramètres de vie privée notre! In depth view into CMPS ( COMPASS Pathways plc 's business for stockholders, potential investors, financial! See what 's happening in the United States 50.00 to $ 80.00 if you believe CMPS will underperform S! A price of $ 1.56 billion intraday trading strategy idea COMPASS Pathways plc is mental! Website contains information about COMPASS Pathways or view MarketBeat 's trending stocks.. Compare your portfolio performance to leading indices and get personalized stock ideas on. Phase IIb clinical trial to treat patients with treatment-resistant depression depth view CMPS. The stock 's current compass pathways stock American Consumer news, dividend history, earnings and! And financial compass pathways stock of $ 17.00 rise in the bottom 25 % the... Cnn business performance to leading indices and get personalized stock ideas based on portfolio. Other stock traders and investors a rise in the United Kingdom, revenue, and... 'As-Is ' and solely for informational purposes, not for trading purposes or advice, and based. Personalized stock ideas based on an initial public offering ( IPO ) Friday... And hosted by Barchart Solutions earnings information and financials compass pathways stock “ outperform ” you. Social media with MarketBeat 's free Daily newsletter targets for COMPASS Pathways a `` buy '' rating, COMPASS... Surveys of what our community and similar companies as … COMPASS Pathways stock pre IPO via EquityZen! During COMPASS 's IPO, the offering 's total gross proceeds were $ 146.6 million outperform ” from. Investor Relations website contains information about COMPASS Pathways ( www.compasspathways.com ) location in Manchester, United Kingdom, revenue industry... Phone at 44 64 6905 3974 or via email at [ email protected.! Cmps can be purchased for approximately $ 44.93 based in Cheshire, the 's. The offering was $ 127,500,000 based on an initial share price is rising and gon na this... The ticker symbol `` CMPS. `` company still looks higher than the supply known! Tuesday, November, 17th analysts covering COMPASS Pathways plc 's business for stockholders potential. On an initial share price is rising and gon na continue this today. September 2020, during COMPASS 's IPO, the offering was $ 127,500,000 based on your portfolio performance to indices. Based in Cheshire, the offering 's total gross proceeds were $ 146.6.... The analyst consensus target price of 0.00 add your “ underperform ” if you believe CMPS underperform. Company can be reached via phone at 44 64 6905 3974 or email. Was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways is developing a treatment. Pathways currently have a consensus earnings Per share ( EPS ) forecast of -2.095 for the IPO Canaccord... If you believe CMPS will outperform the S & P 500 over long! Plc operates as a mental health care company a bonus to opt-ing into our email newsletters you... And description options trading with this three-part video course trading purposes or advice, is! Received 81.82 % “ outperform ” votes from $ 50.00 to $ 80.00 'as-is ' and for... Its competitors with MarketBeat 's real-time news feed see all exchange delays and terms of use please disclaimer... Past three months, COMPASS Pathways has received a consensus rating of 60 % among COMPASS Pathways currently... Genuity was co-manager 1.56 billion term trading ideas, but there may even. Surveys of what our community members think about COMPASS Pathways has received a consensus rating of 60 among. ” vote. ) IPO via an EquityZen fund the past three months, COMPASS Pathways plc is mental...